232 related articles for article (PubMed ID: 28610844)
1. Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation.
Oblinger JL; Burns SS; Huang J; Pan L; Ren Y; Shen R; Kinghorn AD; Welling DB; Chang LS
Exp Neurol; 2018 Jan; 299(Pt B):299-307. PubMed ID: 28610844
[TBL] [Abstract][Full Text] [Related]
2. eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.
Boussemart L; Malka-Mahieu H; Girault I; Allard D; Hemmingsson O; Tomasic G; Thomas M; Basmadjian C; Ribeiro N; Thuaud F; Mateus C; Routier E; Kamsu-Kom N; Agoussi S; Eggermont AM; Désaubry L; Robert C; Vagner S
Nature; 2014 Sep; 513(7516):105-9. PubMed ID: 25079330
[TBL] [Abstract][Full Text] [Related]
3. Natural compounds as potential treatments of NF2-deficient schwannoma and meningioma: cucurbitacin D and goyazensolide.
Spear SA; Burns SS; Oblinger JL; Ren Y; Pan L; Kinghorn AD; Welling DB; Chang LS
Otol Neurotol; 2013 Oct; 34(8):1519-27. PubMed ID: 23928514
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitor AR-42 differentially affects cell-cycle transit in meningeal and meningioma cells, potently inhibiting NF2-deficient meningioma growth.
Burns SS; Akhmametyeva EM; Oblinger JL; Bush ML; Huang J; Senner V; Chen CS; Jacob A; Welling DB; Chang LS
Cancer Res; 2013 Jan; 73(2):792-803. PubMed ID: 23151902
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model.
Bordeleau ME; Robert F; Gerard B; Lindqvist L; Chen SM; Wendel HG; Brem B; Greger H; Lowe SW; Porco JA; Pelletier J
J Clin Invest; 2008 Jul; 118(7):2651-60. PubMed ID: 18551192
[TBL] [Abstract][Full Text] [Related]
6. Two related trypanosomatid eIF4G homologues have functional differences compatible with distinct roles during translation initiation.
Moura DM; Reis CR; Xavier CC; da Costa Lima TD; Lima RP; Carrington M; de Melo Neto OP
RNA Biol; 2015; 12(3):305-19. PubMed ID: 25826663
[TBL] [Abstract][Full Text] [Related]
7. Manipulation of the host translation initiation complex eIF4F by DNA viruses.
Walsh D
Biochem Soc Trans; 2010 Dec; 38(6):1511-6. PubMed ID: 21118117
[TBL] [Abstract][Full Text] [Related]
8. Signalling to eIF4E in cancer.
Siddiqui N; Sonenberg N
Biochem Soc Trans; 2015 Oct; 43(5):763-72. PubMed ID: 26517881
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome-wide characterization of the eIF4A signature highlights plasticity in translation regulation.
Rubio CA; Weisburd B; Holderfield M; Arias C; Fang E; DeRisi JL; Fanidi A
Genome Biol; 2014; 15(10):476. PubMed ID: 25273840
[TBL] [Abstract][Full Text] [Related]
10. Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G.
Moerke NJ; Aktas H; Chen H; Cantel S; Reibarkh MY; Fahmy A; Gross JD; Degterev A; Yuan J; Chorev M; Halperin JA; Wagner G
Cell; 2007 Jan; 128(2):257-67. PubMed ID: 17254965
[TBL] [Abstract][Full Text] [Related]
11. A new translational regulator with homology to eukaryotic translation initiation factor 4G.
Imataka H; Olsen HS; Sonenberg N
EMBO J; 1997 Feb; 16(4):817-25. PubMed ID: 9049310
[TBL] [Abstract][Full Text] [Related]
12. Eukaryotic translation initiation factors 4G and 4A from Saccharomyces cerevisiae interact physically and functionally.
Neff CL; Sachs AB
Mol Cell Biol; 1999 Aug; 19(8):5557-64. PubMed ID: 10409745
[TBL] [Abstract][Full Text] [Related]
13. eIF4F is a thermo-sensing regulatory node in the translational heat shock response.
Desroches Altamirano C; Kang MK; Jordan MA; Borianne T; Dilmen I; Gnädig M; von Appen A; Honigmann A; Franzmann TM; Alberti S
Mol Cell; 2024 May; 84(9):1727-1741.e12. PubMed ID: 38547866
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer.
Ikeda K; Saeki Y; Gonzalez-Agosti C; Ramesh V; Chiocca EA
J Neurosurg; 1999 Jul; 91(1):85-92. PubMed ID: 10389885
[TBL] [Abstract][Full Text] [Related]
15. The soy isoflavone equol may increase cancer malignancy via up-regulation of eukaryotic protein synthesis initiation factor eIF4G.
de la Parra C; Otero-Franqui E; Martinez-Montemayor M; Dharmawardhane S
J Biol Chem; 2012 Dec; 287(50):41640-50. PubMed ID: 23095751
[TBL] [Abstract][Full Text] [Related]
16. Acetyl-11-keto-beta-boswellic acid (AKBA) is cytotoxic for meningioma cells and inhibits phosphorylation of the extracellular-signal regulated kinase 1 and 2.
Park YS; Lee JH; Harwalkar JA; Bondar J; Safayhi H; Golubic M
Adv Exp Med Biol; 2002; 507():387-93. PubMed ID: 12664615
[TBL] [Abstract][Full Text] [Related]
17. AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.
Bush ML; Oblinger J; Brendel V; Santarelli G; Huang J; Akhmametyeva EM; Burns SS; Wheeler J; Davis J; Yates CW; Chaudhury AR; Kulp S; Chen CS; Chang LS; Welling DB; Jacob A
Neuro Oncol; 2011 Sep; 13(9):983-99. PubMed ID: 21778190
[TBL] [Abstract][Full Text] [Related]
18. Isolation and functional characterization of eIF4F components and poly(A)-binding protein from Plasmodium falciparum.
Tuteja R; Pradhan A
Parasitol Int; 2009 Dec; 58(4):481-5. PubMed ID: 19751846
[TBL] [Abstract][Full Text] [Related]
19. Human eIF4E promotes mRNA restructuring by stimulating eIF4A helicase activity.
Feoktistova K; Tuvshintogs E; Do A; Fraser CS
Proc Natl Acad Sci U S A; 2013 Aug; 110(33):13339-44. PubMed ID: 23901100
[TBL] [Abstract][Full Text] [Related]
20. Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E.
Pyronnet S; Imataka H; Gingras AC; Fukunaga R; Hunter T; Sonenberg N
EMBO J; 1999 Jan; 18(1):270-9. PubMed ID: 9878069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
